Patients received 1.5-2 g (mean 1.7 g) (20 mg/kg ) sodium stibogluconate intravenously daily for 20 complex requires treatment with parenteral pentavalent antimonials to prevent development of mucodays. All developed transient musculoskeletal symptoms and asymptomatic hepatitis. Eleven developed cutaneous leishmaniasis. Patients with imported disease are usually managed in hospital because of biochemical pancreatitis, and one thrombocytopenia. Three developed transient ECG changes and concerns over drug toxicity. This study describes the clinical features and outcome of infection one herpes zoster. There were four device-related infections, two requiring hospitalization (one treated in the UK in an out-patient setting. Thirteen marines (aged 19-35 years) who acquired leishmanirequired surgical drainage of an abscess). All lesions re-epithelialized. A total of 250 bed-days were saved asis in Belize were studied prospectively. Three had at least two lesions (0.6-3 cm diameter), eight had over a 67-day period. These results indicate that in selected patients, out-patient therapy for cutaneous regional lymphadenopathy and one had localized painless lymphatic thickening. Histology for amastigleishmaniasis with parenteral high-dose sodium stibogluconate may be appropriate, provided there is otes and PCR for Leishmania braziliensis complex was positive in all. Culture was positive in six.
Introduction
Leishmaniasis is a group of parasitic, vector-born isolated are Leishmania braziliensis braziliensis and to a lesser extent Leishmania mexicana mexicana.1,2 diseases caused by a number of different Leishmania species. Infection is acquired in the tropics and subPatients with L. mexicana complex normally suffer a self-limiting infection with no subsequent sequelae. tropics following the bite of an infected sand fly. Disease may range from self-limiting skin lesions to Patients infected with L. b. braziliensis, however, have the potential to develop the muco-cutaneous life-threatening visceral or muco-cutaneous forms. The natural reservoir for Leishmania species is mamform, months to years later.3 To prevent this potentially disfiguring and life-threatening complication, mals (usually rodents or dogs). In the UK, there is no formal reporting system or national reference and to hasten healing of the cutaneous lesion, patients are treated with sodium stibogluconate,3,4 a laboratory for leishmaniasis, so estimates of numbers are difficult. Amongst visitors to Central and South pentavalent antimony compound with welldocumented transient adverse effects. These include America, a group at particular high risk of cutaneous leishmaniasis is servicemen, who may train for weeks musculoskeletal symptoms, liver and marrow toxicity, pancreatitis and electrocardiographic abnorin dense jungle with intense exposure to the sandfly vectors. In such a setting, the main species malities. In view of the potential toxicity and the need for prolonged intravenous therapy, patients are doses were self-prepared and administered under supervision in the marine base. Subsequent doses usually hospitalized for the full treatment course (usually 20 days).
were provided by the hospital pharmacy and administered in the marine base sick bay under the Between September and December 1998, approximately 450 marines from Marine Base Condor, supervision of the medical orderly. The nurse practitioner provided advice and liaised with medical staff Arbroath, took part in a training exercise in rainforest in southern Belize. Prior to departure from the UK, on the infectious disease unit regarding problems. An existing 24-h help line for out-patients was made the marines had been briefed on the risk of leishmaniasis and strategies for avoiding sand-fly bites. On available to the marines. Patients were reviewed at least weekly by the infectious disease physician. return, a number reported non-healing ulcers on arms and legs. This paper outlines the clinical Intravascular device dressings were changed, and renal function, liver function, amylase, full blood features, therapy and outcome for 13 marines with confirmed cutaneous Leishmania braziliensis comcount and electrocardiographic measurements were made on days 4, 7, 14, 20, and again 3 weeks after plex infection treated in an out-patient setting.
cessation of therapy.
Methods Results
Patients with suspected leishmaniasis were referred
Clinical features
by the medical officer of Condor to the Infection and Immunodeficiency Unit, Dundee Teaching A total of 13 patients were treated between Hospitals NHS Trust, for assessment. Patients under31st December 1998 and 7th March 1999 (Table 1) . went a clinical examination, biopsy of lesion(s), All were male (aged 19-35 years). All gave typical base-line electrolyte measurements, full blood count, histories of papules which appeared on an extremity liver function tests and electrocardiogram.
whilst in the Belize jungle. These increased in size Biopsies were performed at the edge of the skin and became ulcerated over 1-3 months. Ten had lesion and were sent formalin-fixed to histology and single lesions, and three had at least two lesions. in sterile saline to the Department of Parasitology, Lesions were typically 0.6-3 cm diameter with centHospital for Tropical Diseases, London. Half the ral crusting and ulceration with an erythematous sample was used for culture on modified Novyindurated margin ( Figure 1 ). In one patient there was MacNeal-Nicolle biphasic media, using tryptose agar an associated staphylococcal cellulitis. Eight had base, with either defibrinated rabbit or human blood regional lymphadenopathy (including two with and quarter-strength Ringer's solution overlay. lymphangitis) and one had localized painless lymphStreptomycin and penicillin were incorporated to atic thickening associated with a forearm lesion. prevent bacterial contamination, and the plates were There were no other systemic features of leishincubated at 26°C for 21 days. The other half of the maniasis. sample was used for a Giemsa-stained impression Microscopy of formalin-fixed Giemsa-stained skin smear and DNA extraction for PCR. Primers working biopsies confirmed intracellular amastigotes in all on the minicircles in the kinetoplast DNA, specific patients. Giemsa-stained impression smears were for L. braziliensis complex and L. mexicana complex positive in 10 patients, and culture grew typical were used.5 promastigotes after 7 days in six patients. In two Patients with suspected leishmaniasis were compatients, culture was contaminated by fungal or menced on intravenous sodium stibogluconate bacterial growth, and in five the parasites failed to 20 mg/kg (no upper limit), and were treated for at grow by 21 days of incubation. PCR of tissue samples least 20 days until the lesions were healed. Sodium in all 13 was positive for L. braziliensis complex. stibogluconate was administered in 5% dextrose PCR for L. mexicana complex was negative in all. solution via an aseptically placed peripherally inserted central catheter over 30 min. Patients were Outcome and complications of therapy advised on potential and likely side-effects, were advised to abstain from alcohol for the duration of Twelve patients completed 20 days uninterrupted treatment with sodium stibogluconate with dosages therapy, and were taught by a nurse practitioner to prepare and self-administer the infusion and to care of 1.5-2 g daily (mean 1.7 g) ( Table 2) . One patient interrupted treatment for one day due to thrombocyfor the intravascular device. The unit pharmacist provided each patient with information regarding topenia. One patient was treated on an out-patient basis for 5 days of the 20-day course in Newcastle potential adverse effects of the drug. The first dose was administered by the nurse practitioner in the Infectious Disease Unit because of work commitments in that region. ward out-patient area. The second, third, and fourth All patients developed moderately severe myalgia, activities whilst on treatment. All patients had elevation in alanine aminotransferase above the normal arthralgia or headaches and malaise which restricted range during therapy, and 11 patients had an asympensis subspecies in Belize. Up until 1984, infection with L. braziliensis complex was not described in tomatic increase in serum amylase. The median time to peak ALT level was 14 days (6-20 days). At Belize, L. mexicana mexicana being the sole isolate described.2 Subsequently, isoenzyme characterisfollow-up 3 weeks later (12 patients), all had declined significantly from peak levels, although in five ation of isolates has shown the dominant species to be indistinguishable from L. braziliensis braziliensis patients levels were slightly above the normal range (Table 2 ). In the eleven patients with elevation in but distinct from L. b. panamensis and guyanensis. 2 This finding has been confirmed more recently in a serum amylase, the median time to peak was 16 days (3-20 days). In ten patients, levels declined to large series of British troops with cutaneous leishmaniasis where 78/107 were infected with L. b. normal levels following cessation of therapy. One patient with an ALT of 69 IU/L and an amylase of braziliensis.1 To our knowledge, muco-cutaneous leishmaniasis has only been described in one patient 193 IU/L at completion of therapy (5-day peak level of 287 IU/L) failed to attend for review as he had from Belize.6 However, cutaneous lesions have recurred up to 19 months after successful treatment, been posted overseas.
There were no abnormalities of renal function demonstrating that infection may lie dormant,1 and the high incidence of lymphadenopathy suggests during therapy. Three patients developed ECG changes with ST flattening in antero-lateral or inferopossible early dissemination.7 It is possible that muco-cutaneous leishmaniasis appears to be infrelateral leads in the third week of treatment. These changes had resolved by 3 weeks post treatment. quent in Belize because the patients described with L. braziliensis complex infection are usually serviceFour patients developed Staphylococcus aureus intravascular-device-related infections. Two were men who have all been treated with sodium stibogluconate after acute infection.1,6 hospitalized for 5 days, and both received intravenous then oral flucloxacillin. One of these developed
In this series, PCR enabled rapid species complex identification, and enabled us to make informed an abscess (which required surgical drainage) and thrombocytopenia (platelet count of 96 000/mm3) decisions about treatment. Such identification would not have been possible otherwise for all patients which improved following treatment of the soft tissue infection and omission of one dose of sodium since two parasite cultures were contaminated, and five positive smears failed to grow. Hence only 6/13 stibogluconate. Two patients were managed with oral flucloxacillin as out-patients without complicapatients could have gone on to species diagnosis by isoenzyme analysis without PCR. These findings are tion. Two further patients developed leaks in their intravascular devices which required replacement. consistent with those of others who found PCR to be consistently more sensitive than other methods of One patient developed herpes zoster whilst on treatment, although he was not lymphopenic at diagnosis.8
The clinical features described are in keeping with any time.
All patients were reviewed on completion of the experience of others.1,3,6,7 Although another series from Belize described a high proportion (27%) of therapy and all lesions had re-epithelialized ( Figure 2 ).
isolates to be L. mexicana mexicana1 we only detected L. braziliensis complex using highly sensitAs a result of our out-patient home parenteral antibiotic programme, a total of 250 bed-days were ive PCR for both species complexes. Since the infections in our series occurred at around the same saved over a 67-day period, or the equivalent of approximately four occupied beds for the same time and in the same well-defined geographical area, it is not unlikely that the infecting organism was the period. During this same period there were 200 acute admissions to our unit with an average stay of same in all 13 patients. The response to high-dose treatment was good, 6.33 days, and bed occupancy rate was approximately 90%.
all lesions having re-epithelialized at 3 weeks posttreatment. Ballou et al. demonstrated 100% cure in 19 patients at 9 weeks post-cessation of therapy with 20 mg/kg stibogluconate compared to 76% cure in Discussion 21 patients treated with 10 mg/kg.9 Others have reported cure rates of between 48.5% and 63.9% Cutaneous leishmaniasis is an unusual condition in the UK which should be considered in any person after shorter course treatment with 600-800 mg daily for 10 days or 1200 mg given for 10-14 days.1 with a slow-to-heal ulcer who has travelled to the tropics or sub-tropics. Species complex diagnosis is
Aronson et al. used 20 mg/kg daily for 20 days in 83 patients with New World cutaneous leishmaniasis, important in New World cutaneous leishmaniasis, in view of the propensity for the braziliensis complex and effected cure in 91% of cases.6 Confirmation of cure is difficult and usually relies on culture of postto progress to muco-cutaneous leishmaniasis. There is some debate over the pathogenicity of the brazilitreatment biopsies. This was not performed in our patients, as only 6/13 pre-treatment had positive strain on the inpatient work-load of our unit at a time of year when bed occupancy was high. The cultures. The PCR technique which detects kinetoplast DNA can not differentiate between live and provision of a nurse-led out-patient and home parenteral antibiotic therapy programme (OHPAT) followdead parasites, so cannot be used to assess cure.
Adverse events were frequent and in keeping with ing strict selection and management guidelines14 allowed these patients to be managed and monitored others' experience.1,3,6,9-11 The most clinically significant were musculoskeletal symptoms, which were successfully and safely at home. This service was developed in April 1998, and to date has managed experienced by all patients to some degree. Biochemical pancreatitis and hepatitis were also over 100 patients with serious infections (mainly infections of skin and soft tissue, bone and joint and common, but clinically insignificant and transient. Ballou et al. showed that hepatitis was more marked endocarditis) with 94% clinical cure (unpublished data). In the present series, two serious device-related in patients receiving 20 mg/kg than 10 mg/kg, although transaminases all returned to baseline folinfections occurred. One responded promptly to device removal and parenteral antibiotic therapy, the lowing cessation of therapy.9 Musculoskeletal symptoms were also more frequent in the group receiving other to drainage of the abscess and parenteral antibiotic therapy. Such adverse events in patients 20 mg/kg.9 Likewise, transient electrocardiographic changes which are well described4,6,9,11 were seen receiving parenteral therapy (either as in-patients or out-patients) are well recognized and probably a in one quarter of our patients. Herpes zoster infection complicated treatment in one patient. It has been major reason for the lack of use of this resource in the UK.15 Results from a US survey of out-patient suggested that this complication arises as a result of lymphopenia secondary to stibogluconate.11 antibiotic therapy indicated a 9% complication rate in patients receiving antibiotics through a peripherAlthough our patient maintained a lymphocyte count within the normal range throughout therapy, a transially inserted central catheter. Only 2% of patients developed device-related infections and 3% required ent decrease cannot be excluded.
Despite the range of adverse effects, none was rehospitalization.16 The relatively high complication rate seen in our patients was also higher than our severe enough to necessitate discontinuation of therapy, and all were transient in nature. This is in own experience to date when treating bacterial infections. In 88 patients treated, six (7%) have contrast to the experience of Aronson et al. who interrupted treatment in 28% of 96 patients treated required readmission, and five (6%) have had microbiologically-proven device-related infections (unpubwith 20 mg/kg. 6 Death attributable to antimony is rare, and is lished data). The high rate of device-related infections in our marine cohort is likely to reflect poor compliprobably due to accumulation of the drug due to renal insufficiency, leading to cardiac or pancreatic ance with asepsis and over-manipulation of the device by the patients. toxicity. In Aronson's series of 96 patients treated with 20 mg/kg pentostam there were no deaths In summary, an out-patient and home parenteral antibiotic programme is a safe and cost-effective during treatment. The three patients who died did so because of causes unrelated to their infection or means of treating cutaneous leishmaniasis, provided patients are carefully selected and monitored approthe treatment.6 Likewise in Ballou's series of 19 patients there were no deaths.9 In Herwaldt and priately. Berman's review, deaths due to the cardiotoxicity of pentostam occurred only rarely, and only in patients receiving >30 mg/kg/day.4 Three deaths due to
